Form 4: Dolby CFO Robert Park Executes Stock Sale
Statement of Changes in Beneficial Ownership
Dolby Laboratories SVP and CFO Robert Park sold 4,895 shares of Class A common stock on May 12, 2026.
Summary
- Robert J. Park, SVP and Chief Financial Officer of Dolby Laboratories, Inc., sold a total of 4,895 shares of Class A common stock.
- The transactions were executed on May 12, 2026, pursuant to a pre-arranged Rule 10b5-1 trading plan.
- The sales occurred in two batches: 4,504 shares at a weighted average price of $56.6165 and 391 shares at $57.35.
- Following these transactions, the reporting person retains beneficial ownership of 81,490 shares, which includes 48,874 shares underlying restricted stock units.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed via a pre-planned 10b5-1 program, which is standard practice for executive financial planning.
Positives
- The transaction was conducted under a pre-established Rule 10b5-1 trading plan, which is a standard mechanism for executives to sell shares without concerns regarding insider trading.
Negatives
- The sale represents a reduction in the direct equity stake held by a key member of the executive leadership team.
Risks
- Continued divestment by senior management could potentially signal a lack of confidence in near-term share price appreciation to some market participants.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this filing.
Industry Context
StockSavvy.ai notes that executive stock sales under 10b5-1 plans are routine corporate governance events and generally do not reflect fundamental changes in company strategy or performance.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for executives at major technology firms like Dolby to manage personal liquidity while maintaining regulatory compliance.
Stakeholder Impact
- Minimal impact expected on shareholders as the sale was pre-planned and represents a small portion of the executive's total holdings.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 05/12/2026 | Date of the stock sale transactions. |
| 05/14/2026 | Date of filing for the Form 4. |
Keywords
Dolby Laboratories, DLB, Insider Trading, Form 4, CFO, Stock Sale, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.